On March 8, the company announced it was changing Johnson & Johnson Medical Devices to MedTech in order to “reflect the company’s global leadership as a medtech innovator,” according to the press release.
“Our business sits at the compelling intersection of medical devices and medical technology, and as the world’s most broadly based medtech company, we are committed to delivering breakthrough scientific innovation and reimagining health in an increasingly digital world,” Ashley McEvoy, executive vice president, worldwide chairman of Johnson & Johnson MedTech said.
The name change comes after the pharmaceutical giant announced the split into two companies on Nov. 12, with one public company being dedicated to medical devices and pharmaceuticals and another dedicated to consumer health products.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
